SB 17 Louisiana Senate · 2024 Regular Session

CONTROL DANGER SUBSTANCE: Adds Tianeptine to Schedule I of the Uniform Controlled Dangerous Substance Law. (8/1/24)

This bill adds Tianeptine to Schedule I of Louisiana's Uniform Controlled Dangerous Substances Law. By doing so, it classifies the substance as a drug with no accepted medical use and a high potential for abuse, making its possession, sale, and distribution illegal under state law. The change applies to Tianeptine in any form, including its salts and isomers, unless it is part of a pharmaceutical product approved by the U.S. Food and Drug Administration. This legislative action directly affects individuals who manufacture, distribute, or possess the substance and law enforcement officers who enforce these regulations.
Bill status signed all 5 stages cleared
Introduction
Feb 2024
Committee Review
Apr 2024
Senate Passage
Mar 2024
House Passage
May 2024
Signed into Law
May 2024
Introduced Feb 25, 2024 Signed May 22, 2024
Floor votes · Senate Mar 18, 2024 · House May 15, 2024

How they voted

370
Passed
Total votes 37
Mar 18, 2024
D Democratic12
12 Yea
100% Yea
R Republican25
25 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
18
Key actions
4
Committee
4
Amendments
1
May 15, 2024
Lower · Passed
Read third time by title, roll called on final passage, yeas 92, nays 0. Finally passed, ordered to the Senate.
lower
May 1, 2024
Introduced
Reported without Legislative Bureau amendments.
lower
Apr 30, 2024
Lower · Passed
Reported favorably (12-0). Referred to the Legislative Bureau.
lower
Mar 20, 2024
Committee
Read by title, under the rules, referred to the Committee on Administration of Criminal Justice.
lower
Mar 18, 2024
Upper · Passed
Read by title, passed by a vote of 39 yeas and 0 nays, and sent to the House. Motion to reconsider tabled.
upper
Mar 12, 2024
Upper · Passed
Reported favorably.
upper
Mar 11, 2024
Committee
Introduced in the Senate; read by title. Rules suspended. Read second time and referred to the Committee on Judiciary C.
upper
1 primary · 24 co-sponsors

Sponsors